Director, Oncology Key Account & Regional Marketing
NateraFull Time
Expert & Leadership (9+ years)
The Principal Medical Key Account Lead must have experience in leading medical interfaces with key health systems, academic medical centers, GPOs, and Pathway accounts, focusing on HIV and oncology. This role requires the ability to develop sustainable customer relationships and communicate clinical, scientific, health economic, and outcomes research data, including real-world evidence and patient-reported outcomes. The position also necessitates developing and executing strategic medical plans and tactics for assigned accounts, generating real-world evidence data, and collaborating with internal teams such as Commercial Oncology Key Account Directors, HIV Institutional Account Directors, Therapeutic Area Medical Science Liaisons, Clinical Development, Clinic Operations, and home office medical matrix teams. A strong understanding of patient access, the evolving healthcare environment, and customer needs is essential.
The Principal Medical Key Account Lead will be responsible for developing and maintaining access to key account stakeholders to facilitate scientific interchange for Gilead's HIV and oncology innovations, with a priority on launch products. They will develop strategic medical plans and tactics for their accounts, implement customer-specific Real-World Evidence (RWE) data generation, and work with PAQ strategy teams to interpret and disseminate data assessing the medical value of Gilead's portfolio. This role involves managing approximately 10-15 critical key accounts, primarily the largest US academic health and key health systems, and collaborating with commercial and medical affairs colleagues. The lead will provide strong leadership in developing account-specific medical strategies related to patient access and the healthcare environment. Additionally, they will effectively communicate approved clinical, scientific, and outcomes data, and accurately respond to customer questions during scientific exchanges with various stakeholders, including access and policy decision-makers, department heads, executive medical and institutional stakeholders, scientific advisors, and healthcare policymakers.
Develops and commercializes biopharmaceuticals
Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.